Last update 06 Mar 2026

JL4083

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
JL4083
Target-
Action-
Mechanism-
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
Influenza A virus infectionInfluenza B virus infection
Inactive Indication-
Originator Organization
Sichuan Jianlin Pharmaceutical Co., Ltd.
Active Organization
Sichuan Jianlin Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with JL4083
CTR20260261
/ Not yet recruitingPhase 1
JL4083吸入溶液在中国健康成年受试者中多次给药的安全性、耐受性、药代动力学 I 期临床试验
[Translation] Safety, tolerability, and pharmacokinetics of JL4083 inhalation solution in multiple-dose Phase I clinical trials in healthy adult subjects in China.
CTR20260257
/ Not yet recruitingPhase 1
在中国健康成年受试者中单次吸入JL4083吸入溶液和静脉注射帕拉米韦氯化钠注射液 后评价肺部药物浓度的I期临床试验
[Translation] A Phase I clinical trial evaluating pulmonary drug concentrations following a single inhalation of JL4083 inhalation solution and intravenous administration of peramivir sodium chloride injection in healthy adult subjects in China.
CTR20260260
/ Not yet recruitingPhase 1
在中国健康成年受试者中单次吸入JL4083吸入溶液和静脉注射帕拉米韦氯化钠注射液后评价血浆和鼻咽部药物浓度的I期临床试验
[Translation] A Phase I clinical trial evaluating plasma and nasopharyngeal drug concentrations following a single inhalation of JL4083 inhalation solution and intravenous administration of peramivir sodium chloride injection in healthy adult subjects in China.
100 Clinical Results associated with JL4083
Login to view more data
100 Translational Medicine associated with JL4083
Login to view more data
100 Patents (Medical) associated with JL4083
Login to view more data
100 Deals associated with JL4083
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Influenza A virus infectionPhase 1
China
Sichuan Jianlin Pharmaceutical Co., Ltd.
26 Jan 2026
Influenza B virus infectionPhase 1
China
Sichuan Jianlin Pharmaceutical Co., Ltd.
26 Jan 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free